Novartis Reports Positive Data for Neuromuscular Disorder Drug

Bayer Shares Hinge On Two Court Decisions After $60 Billion Rout

AI-Driven Genomic Revolution Reshapes $50+ Billion GM Foods Market as Food Security Concerns Intensify

Bayer Advances Asundexian And KERENDIA As Shares Trade Well Below Targets

Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions

Novartis' Rhapsido Meets Primary Goal in Phase III Skin Disorder Study

Bayer (BAYRY) Upgraded to Buy: What Does It Mean for the Stock?

Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief

Natur Tec India and Bayer to Develop Compostable Seedling Cups

Bayer Completes Acquisition of Perfuse Therapeutics